How is the Zenas Biopharma Inc. today?

The Zenas Biopharma Inc. today is trading in the down by -4.70% at 10.94.

How has Zenas Biopharma Inc. performed historically?

The Zenas Biopharma Inc. is currently trading down -4.70% on an intraday basis in the past week the index rose 4.49%. The index has been up 4.49% in the past quarter and rose 4.49% in the past year. You can view this in the overview section.

What is Zenas Biopharma Inc. Annual Revenue?

Zenas Biopharma Inc. Annual Revenue fell 90%, in the last year to $5 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Zenas Biopharma Inc. Annual Net Profit?

Zenas Biopharma Inc. Annual Net Profit fell 322.87% in the last year to $156.99 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Zenas Biopharma Inc. Price to Earning Ratio?

Zenas Biopharma Inc. Price to Earning Ratio is -2.92, which is negative.

What is Zenas Biopharma Inc. Stock Price?

Zenas Biopharma Inc. Stock Price rose 4.49% and underperformed its sector by 6.84% in the past year.

What is Zenas Biopharma Inc. Quarterly Net profit?

Zenas Biopharma Inc. Quarterly Net profit fell 113.95% YoY to $52.6 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is Zenas Biopharma Inc. Debt to Equity Ratio?

Zenas Biopharma Inc. Debt to Equity Ratio is zero as the company is debt-free.

What is Zenas Biopharma Inc. Return on Equity(ROE)?

Zenas Biopharma Inc. Return on Equity(ROE) for the last financial year was -361.99%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Zenas Biopharma Inc. Mutual Fund Holding?

Zenas Biopharma Inc. Mutual Fund Holding increased by 0.07% in the last quarter to 22.63.

What is Zenas Biopharma Inc. Institutional Holding?

Zenas Biopharma Inc. Institutional Holding increased by 3.29% in the last quarter to 79.05.

Zenas Biopharma Inc. XNAS: ZBIO

Zenas Biopharma Inc. Live Share Price Today, Share Analysis and Chart

Name: Zenas Biopharma Inc.: Is Infosys Ltd. worth buying?
Item: Zenas Biopharma Inc.
Rating: 0.28333325
Author: Trendlyne DVM scores

about

Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the a...

10.94 -0.54 (-4.70%)

New 52W High today

121.4K XNAS Volume

XNAS 21 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Zenas Biopharma Inc. is on 30 May 2025 for the purpose of Zenas BioPharma Inc First Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

11.3 / 100

Technically Bearish

0.0 / 100

1Yr Price target upside is 194%

7 analysts

Zenas Biopharma Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Zenas Biopharma Inc. Live Share Price Today, Share Analysis and Chart

Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the a...

New 52W High today

SWOT Analysis

Zenas Biopharma Inc. Live Price Chart

Zenas Biopharma Inc. FAQ

How is Zenas Biopharma Inc. today?

Zenas Biopharma Inc. today is trading in the red, and is down by -4.70% at 10.94.

How has Zenas Biopharma Inc. performed historically?

Zenas Biopharma Inc. is currently trading down -4.70% on an intraday basis. In the past week the stock rose 4.49%. stock has been up 4.49% in the past quarter and rose 4.49% in the past year. You can view this in the overview section.